China Universal Asset Management »

Adma Biologics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $860k 50k 17.15
2024-09-30 $896k 45k 19.99
2024-06-30 $305k 27k 11.18
2024-03-31 $290k 44k 6.60
2023-12-31 $118k 26k 4.52
2023-09-30 $21k 5.8k 3.58
2023-06-30 $11k 2.9k 3.69
2023-03-31 $9.9k 3.0k 3.31
2022-12-31 $7.8k 2.0k 3.88
2022-09-30 $4.0k 1.8k 2.18

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Nuveen Asset Management
Geode Capital Management
D. E. Shaw & Co
Two Sigma Advisers
AWM Investment Company
American Century Companies
Deutsche Bank Aktiengesellschaft
Dimensional Fund Advisors
Renaissance Technologies
Perpetual
Two Sigma Investments

View all funds holding Adma Biologics